Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms.
de Melo Campos P, Machado-Neto JA, Eide CA, Savage SL, Scopim-Ribeiro R, da Silva Souza Duarte A, Favaro P, Lorand-Metze I, Costa FF, Tognon CE, Druker BJ, Olalla Saad ST, Traina F. de Melo Campos P, et al. Among authors: olalla saad st. Oncotarget. 2016 Feb 9;7(6):6948-59. doi: 10.18632/oncotarget.6851. Oncotarget. 2016. PMID: 26755644 Free PMC article.
Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms.
Traina F, Visconte V, Elson P, Tabarroki A, Jankowska AM, Hasrouni E, Sugimoto Y, Szpurka H, Makishima H, O'Keefe CL, Sekeres MA, Advani AS, Kalaycio M, Copelan EA, Saunthararajah Y, Olalla Saad ST, Maciejewski JP, Tiu RV. Traina F, et al. Among authors: olalla saad st. Leukemia. 2014 Jan;28(1):78-87. doi: 10.1038/leu.2013.269. Epub 2013 Sep 18. Leukemia. 2014. PMID: 24045501
Immunomodulatory Effect of Green Tea Treatment in Combination with Low-dose Chemotherapy in Elderly Acute Myeloid Leukemia Patients with Myelodysplasia-related Changes.
Calgarotto AK, Longhini AL, Pericole de Souza FV, Duarte ASS, Ferro KP, Santos I, Maso V, Olalla Saad ST, Torello CO. Calgarotto AK, et al. Among authors: olalla saad st. Integr Cancer Ther. 2021 Jan-Dec;20:15347354211002647. doi: 10.1177/15347354211002647. Integr Cancer Ther. 2021. PMID: 33754891 Free PMC article.
Imatinib restores VASP activity and its interaction with Zyxin in BCR-ABL leukemic cells.
Bernusso VA, Machado-Neto JA, Pericole FV, Vieira KP, Duarte AS, Traina F, Hansen MD, Olalla Saad ST, Barcellos KS. Bernusso VA, et al. Among authors: olalla saad st. Biochim Biophys Acta. 2015 Feb;1853(2):388-95. doi: 10.1016/j.bbamcr.2014.11.008. Epub 2014 Nov 15. Biochim Biophys Acta. 2015. PMID: 25450971 Free article.
Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412.
de Melo Campos P, Machado-Neto JA, Scopim-Ribeiro R, Visconte V, Tabarroki A, Duarte AS, Barra FF, Vassalo J, Rogers HJ, Lorand-Metze I, Tiu RV, Costa FF, Olalla Saad ST, Traina F. de Melo Campos P, et al. Among authors: olalla saad st. Leuk Res. 2014 Oct;38(10):1245-51. doi: 10.1016/j.leukres.2014.07.010. Epub 2014 Aug 1. Leuk Res. 2014. PMID: 25139846 Free article.
67 results